FDA Inspection 1070597 — Jae Hong Park, MD
The FDA completed an inspection of Jae Hong Park, MD on Sep 20, 2018 in Yangsan-Si. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Yangsan-Si (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)